Effect of prophylactic beta-glucan use on the incidence of neutropenic fever and survival rates in pediatric patients with sarcoma


Creative Commons License

ÖZKAN A., KÜPELİ S., Cil M., SEZGİN G., BAYRAM İ.

CUKUROVA MEDICAL JOURNAL, vol.47, no.2, pp.596-602, 2022 (ESCI, TRDizin)

  • Publication Type: Article / Article
  • Volume: 47 Issue: 2
  • Publication Date: 2022
  • Doi Number: 10.17826/cumj.1039267
  • Journal Name: CUKUROVA MEDICAL JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Academic Search Premier, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.596-602
  • Keywords: Beta-glucan, neutropenic fever, pediatric sarcomas, survival, CANCER, OSTEOSARCOMA, CHEMOTHERAPY, GUIDELINE, BLOOD
  • Open Archive Collection: AVESIS Open Access Collection
  • Çukurova University Affiliated: Yes

Abstract

Purpose: Some patients with cancer use herbal therapy as an adjunct while receiving conventional cancer treatments. Beta-glucans have direct cytotoxic effects on cancer cells as well as stimulatory effects on the immune system. In this study, a nutritional supplement containing 1,3-1,6 beta-glucan obtained from baker's yeast (Saccharomyces cerevisiae) was used by patients diagnosed with sarcoma, and this study aimed to retrospectively evaluate the effect of beta-glucan use on the incidence of neutropenic fever (NF) and survival rates.